WE Communications: Ledger

Stories naming WE Communications. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.

Investor	Rounds	Invested
No investors recorded yet. Know one?

Company	Kind	Announced	Price	Sources
WE Communications is not recorded as having acquired anything.

Funding announcement

Vaxxas Announces Interim Phase I Study Results for First Needle-Free HD-MAP COVID-19 Vaccine

Vaxxas reports encouraging interim Phase I results for its needle-free microarray-patch COVID-19 vaccine, with strong antibody responses and no serious adverse events, ahead of planned regulatory applications in Australia and the US.

Brandon Capital portfolio 6 Jun 2023 Bill & Melinda Gates Foundation Biomedical Advanced Research and Development Authority Brandon Capital CEPI Healthcare Ventures OneVentures OneVentures Innovation Fund I The University of Queensland The University of Texas at Austin The Yates Network UniQuest University of the Sunshine Coast Vaxxas WE Communications World Health Organization Australian Government Dr David L Hoey

WE Communications

Funding history

Investors

What WE Communications bought

People

Coverage

Vaxxas Announces Interim Phase I Study Results for First Needle-Free HD-MAP COVID-19 Vaccine